Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +3.30% | -5.53% | +16.05% |
Jun. 10 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
May. 16 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.05% | 295M | |
+49.41% | 56.95B | |
+40.49% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Transcript : Tenaya Therapeutics, Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-12-2024 08